Vascular invasion, perineural invasion, and tumour budding: Predictors of outcome in colorectal cancer

Acta Gastro-Enterologica Belgica

Volumn 74, Issue 4, 2011, Pages 516-529

  Betge, Johannes ^a   Langner, Cord ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Colon cancer; Early colorectal cancer; Immunohistochemistry; Lymphatic invasion; Lymphovascular invasion; Multivariable analysis; Outcome; Perineural invasion; Prognosis; Rectal cancer; Tumour budding; Univariable analysis; Vascular invasion; Venous invasion

Indexed keywords

FLUOROURACIL;

CANCER INVASION; CANCER STAGING; CLINICAL EVALUATION; COLORECTAL CANCER; IMMUNOHISTOCHEMISTRY; INFORMATION RETRIEVAL; LYMPH NODE METASTASIS; MORPHOLOGY; OUTCOME ASSESSMENT; PERINEURIUM; PREDICTION; PREDICTOR VARIABLE; PROGNOSIS; RECTUM CANCER; RECURRENT DISEASE; REVIEW; COLORECTAL TUMOR; HUMAN; LYMPH VESSEL; PATHOLOGY; TUMOR RECURRENCE;

COLORECTAL NEOPLASMS; HUMANS; LYMPHATIC VESSELS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS;

EID: 84858034946     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (169)

1. JASS J.R., LOVE S.B., NORTHOVER J.M. A new prognostic classification of rectal cancer. Lancet, 1987, 1: 1303-1306.
2. COMPTON C.C. Optimal pathologic staging: defining stage II disease. Clin. Cancer Res., 2007, 13: 6862-6870.
3. MCLEOD H.L., MURRAY G.I. Tumour markers of prognosis in colorectal cancer. Br. J. Cancer., 1999, 79: 191-203.
4. LYALL M.S., DUNDAS S.R., CURRAN S., MURRAY G.I. Profiling markers of prognosis in colorectal cancer. Clin. Cancer Res., 2006, 12: 1184-1191.
5. NAGTEGAAL I. D,. van de VELde C.J., MARIJNEN C.A., van KRIEKEN J.H., QUIRKE P., DUTCH COLORECTAL CANCER GROUP et al. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J. Clin. Oncol., 2005, 23: 9257-9264.
6. ROSEN L. S, BILCHIK A.J., BEART R.W., JR, BENSON A.B., 3RD, CHANG K.J., COMPTON C.C. et al. New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference. Clin. Cancer Res., 2007, 13: 6853-6856.
7. O'CONNELL J.B., MAGGARD M.A., KO C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J. Natl. Cancer. Inst., 2004, 96: 1420-1425.
8. WASHINGTON M.K., BERLIN J., BRANTON P., BURGART L.J., CARTER D.K., FITZGIBBONS P.L. et al. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch. Pathol. Lab. Med., 2009, 133: 1539-1551.
9. JASS J.R., O'BRIEN J., RIDDELL R.H., SNOVER D.C., Association of Directors of Anatomic and Surgical Pathology. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma: Association of Directors of Anatomic and Surgical Pathology. Am. J. Clin. Pathol., 2008, 129: 13-23.
10. ENGSTROM P.F., ARNOLETTI J.P., BENSON A.B., 3RD, CHEN Y.J., CHOTI M.A., COOPER H.S. et al. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J. Natl. Compr. Canc. Netw., 2009, 7: 778-831.
11. ENGSTROM. PF., ARNOLETTI J.P., BENSON A.B., 3RD, CHEN Y.J., CHOTI M.A., COOPER H.S. et al. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J. Natl. Compr. Canc. Netw., 2009, 7: 838-881.
12. TALBOT I.C., RITCHIE S., LEIGHTON M., HUGHES A.O., BUSSEY H.J., MORSON B.C. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology., 1981, 5: 141-163.
13. MINSKY B.D., MIES C., RICH T.A., RECHT A. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 1989, 17: 311-318.
14. WASHINGTON M.K. Colorectal carcinoma: selected issues in pathologic examination and staging and determination of prognostic factors. Arch. Pathol. Lab. Med., 2008, 132: 1600-1607.
15. BETGE J., POLLHEIMER M.J., LINDTNER R.A., KORNPRAT P., SCHLEMMER A., REHAK P. et al. Intra-and extramural vascular invasion in colorectal cancer-prognostic significance & quality of pathology reporting. Cancer, 2011 (in press).
16. TSUCHIYA A., ANDO Y., KIKUCHI Y., KANAZAWA M., SATO H., ABE R. Venous invasion as a prognostic factor in colorectal cancer. Surg. Today, 1995, 25: 950-953.
17. SATO H., MAEDA K., SUGIHARA K., MOCHIZUKI H., KOTAKE K., TERAMOTO T. et al. High-risk stage II colon cancer after curative resection. J. Surg. Oncol., 2011, 104: 45-52.
18. SHIROUZU K., ISOMOTO H., KAKEGAWA T., MORIMATSU M. A prospective clinicopathologic study of venous invasion in colorectal cancer. Am. J. Surg., 1991, 162: 216-222.
19. KNUDSEN J.B., NILSSON T., SPRECHLER M., JOHANSEN A., CHRISTENSEN N. Venous and nerve invasion as prognostic factors in postoperative survival of patients with resectable cancer of the rectum. Dis. Colon. Rectum., 1983, 26: 613-617.
20. HORN A., DAHL O., MORILD I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis. Colon. Rectum., 1991, 34: 798-804.
21. OUCHI K., SUGAWARA T., ONO H., FUJIYA T., KAMIYAMA Y., KAKUGAWA Y. et al. Histologic features and clinical significance of venous invasion in colorectal carcinoma with hepatic metastasis. Cancer, 1996, 78: 2313-2317.
22. KRASNA M.J., FLANCBAUM L., CODY R.P., SHNEIBAUM S., BEN ARI G. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer, 1988, 61: 1018-1023.
23. INOUE T., MORI M., SHIMONO R., KUWANO H., SUGIMACHI K. Vascular invasion of colorectal carcinoma readily visible with certain stains. Dis. Colon. Rectum,. 1992, 35: 34-39.
24. SUZUKI A., TOGASHI K., NOKUBI M., KOINUMA K., MIYAKURA Y., HORIE H. et al. Evaluation of venous invasion by Elastica van Gieson stain and tumor budding predicts local and distant metastases in patients with T1 stage colorectal cancer. Am. J. Surg. Pathol., 2009, 33: 1601-1607.
25. EGASHIRA Y., YOSHIDA T., HIRATA I., HAMAMOTO N., AKUTA GAWA H., TAKESHITA A. et al. Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer. Mod. Pathol., 2004, 17: 503-511.
26. BAYAR S., SAXENA R., EMIR B., SALEM R.R. Venous invasion may predict lymph node metastasis in early rectal cancer. Eur. J. Surg. Oncol., 2002, 28: 413-417.
27. TALBOT I.C., RITCHIE S., LEIGHTON M.H., HUGHES A.O., BUSSEY H.J., MORSON B.C. Spread of rectal cancer within veins. Histologic features and clinical significance. Am. J. Surg., 1981, 141: 15-17.
28. TALBOT I.C., RITCHIE S., LEIGHTON M.H., HUGHES A.O., BUSSEY H.J., MORSON B.C. The clinical significance of invasion of veins by rectal cancer. Br. J. Surg., 1980, 67: 439-442.
29. MINSKY B.D., MIES C., RICH T.A., RECHT A., CHAFFEY J.T. Potentially curative surgery of colon cancer: the influence of blood vessel invasion. J. Clin. Oncol., 1988, 6: 119-127.
30. HARRISON J.C., DEAN P.J., EL-ZEKY F., VANDER ZWAAG R. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum. Pathol., 1995, 26: 31-38.
31. HORN A., DAHL O., MORILD I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis. Colon. Rectum., 1990,: 598-601.
32. DEANS G.T., PATTERSON C.C., PARKS T.G., SPENCE R.A., HEATLEY M., MOOREHEAD R.J. et al. Colorectal carcinoma: importance of clinical and pathological factors in survival. Ann. R. Coll. Surg. Engl., 1994, 76: 59-64.
33. TAKEBAYASHI Y., AKLYAMA S., YAMADA K., AKIBA S., AIKOU T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer., 1996, 78: 226-231.
34. FUJITA S., SHIMODA T., YOSHIMURA K., YAMAMOTO S., AKASU T., MORIYA Y. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. J. Surg. Oncol., 2003, 84: 127-131.
35. BURTON S., NORMAN A.R., BROWN G., ABULAFI A.M., SWIFT R.I. Predictive poor prognostic factors in colonic carcinoma. Surg. Oncol., 2006, 15: 71-78.
36. CHAPUIS P.H., DENT O., FISHER R., NEWLAND R.C., PHEILS M.T., SMYTH E. et al. A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br. J. Surg., 1985, 72: 698-702.
37. LIANG P., NAKADA I., HONG J.W., TABUCHI T., MOTOHASHI G., TAKEMURA A. et al. Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis. Ann. Surg. Oncol., 2007, 14: 470-477.
38. NEWLAND R.C., DENT O.F., LYTTLE M.N., CHAPUIS P.H., BOKEY E.L. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer., 1994, 73: 2076-2082.
39. FREEDMAN L.S., MACASKILL P., SMITH A.N. Multivariate analysis of prognostic factors for operable rectal cancer. Lancet., 1984, 2: 733-736.
40. TAKAHASHI T., KATO T., KODAIRA S., KOYAMA Y., SAKABE T., TOMINAGA T. et al. Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy. Am. J. Clin. Oncol., 1996, 19: 408-415.
41. TOMINAGA T., SAKABE T., KOYAMA Y., HAMANO K., YASUTOMI M., TAKAHASHI T. et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Cancer., 1996, 78: 403-408.
42. BENTZEN S.M., BALSLEV I., PEDERSEN M., TEGLBJAERG P.S., HANBERG-SOERENSEN F., BONE J. et al. A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis? Br. J. Cancer., 1988, 58: 195-201.
43. CHAPUIS P.H., DENT O.F., BOKEY E.L., NEWLAND R.C., SINCLAIR G. Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer. Br. J. Surg., 2004, 91: 349-354.
44. MINSKY B.D., MIES C., RECHT A., RICH T.A., CHAFFEY J.T. Resectable adenocarcinoma of the rectosigmoid and rectum. II. The influence of blood vessel invasion. Cancer, 1988, 61: 1417-1424.
45. DRESEN R.C., PETERS E.E., RUTTEN H.J., NIEUWENHUIJZEN G.A., DEMEYERE T.B., van DEN BRULE A.J. et al. Local recurrence in rectal cancer can be predicted by histopathological factors. Eur. J. Surg. Oncol., 2009, 35: 1071-1077.
46. HOHENBERGER W., BITTORF B., PAPADOPOULOS T., MERKEL S. Survival after surgical treatment of cancer of the rectum. Langenbecks Arch. Surg., 2005, 390: 363-372.
47. HARRISON J.C., DEAN P.J., EL-ZEKY F., VANDER ZWAAG R. From Dukes through Jass: pathological prognostic indicators in rectal cancer. Hum. Pathol., 1994, 25: 498-505.
48. LIN M., MA S.P., LIN H.Z., JI P., XIE D., YU J.X. Intratumoral as well as peritumoral lymphatic vessel invasion correlates with lymph node metastasis and unfavourable outcome in colorectal cancer. Clin. Exp. Metastasis., 2010, 27: 123-132.
49. OGATA Y., TORIGOE S., MATONO K., SASATOMI T., ISHIBASHI N., SHIDA S. et al. Prognostic factors after potentially curative resection in stage II or III colon cancer. Kurume Med. J., 2005, 52: 67-71.
50. TANG R., HO Y.S., YOU Y.T., HSU K.C., CHEN J.S., CHANGCHIEN C.R. et al. Prognostic evaluation of DNA flow cytometric and histopathologic parameters of colorectal cancer. Cancer, 1995, 76: 1724-1730.
51. MEYER A., MERKEL S., BRUCKL W., SCHELLERER V., SCHILDBERG C., CAMPEAN V. et al. Cdc2 as prognostic marker in stage UICC II colon carcinomas. Eur. J. Cancer, 2009, 45: 1466-1473.
52. PTOK H., MEYER F., STEINERT R., VIETH M., RIDWELSKI K., LIPPERT H. et al. No prognostic impact of isolated lymphovascular invasion after radical resection of rectal cancer--results of a multicenter observational study. Int. J. Colorectal Dis., 2007, 22: 749-756.
53. LIM S.B., YU C.S., JANG S.J., KIM T.W., KIM J.H., KIM J.C. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis. Colon. Rectum, 2010, 53: 377-384.
54. MICHELASSI F., BLOCK G.E., VANNUCCI L., MONTAG A., CHAPPELL R. A 5-to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma. Ann. Surg., 1988, 208: 379-389.
55. MICHELASSI F., AYALA J.J., BALESTRACCI T., GOLDBERG R., CHAPPELL R., BLOCK G.E. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Ann. Surg,. 1991, 214: 11-18.
56. MEGUERDITCHIAN A.N., BAIRATI I., LAGACE R., HAREL F., KIBRITE A. Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am. J. Surg., 2005, 189: 707-713.
57. DU C.Z., XUE W.C., CAI Y., LI M., GU J. Lymphovascular invasion in rectal cancer following neoadjuvant radiotherapy: a retrospective cohort study. World J. Gastroenterol., 2009, 15: 3793-3798.
58. DAS P., SKIBBER J.M., RODRIGUEZ-BIGAS M.A., FEIG B.W., CHANG G.J., HOFF P.M. et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am. J. Clin. Oncol., 2006, 29: 219-224.
59. MEHRKHANI F, NASIRI S, DONBOLI K, MEYSAMIE A, HEDAYAT A. Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis., 2009, 11: 157-161.
60. MORRIS M., PLATELL C., de BOER B., MCCAUL K., IACOPETTA B. Population-based study of prognostic factors in stage II colonic cancer. Br. J. Surg., 2006, 93: 866-871.
61. TSAI H.L., CHENG K.I., LU C.Y., KUO C.H., MA C.J., WU J.Y. et al. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J. Surg. Oncol., 2008, 97: 383-387.
62. PETERSEN V.C., BAXTER K.J., LOVE S.B., SHEPHERD N.A. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut, 2002, 51: 65-69.
63. UEN Y.H., LIN S.R., WU D.C., SU Y.C., WU J.Y., CHENG T.L. et al. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann. Surg., 2007, 246: 1040-1046.
64. LIN C.C., LIN J.K., CHANG S.C., WANG H.S., YANG S.H., JIANG J.K. et al. Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute. Int. J. Colorectal Dis., 2009, 24: 665-676.
65. QUAH H.M., CHOU J.F., GONEN M., SHIA J., SCHRAG D., LANDMANN R.G. et al. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis. Colon. Rectum, 2008, 51: 503-507.
66. LENNON A.M., MULCAHY H.E., HYLAND J.M., LOWRY C., WHITE A., FENNELLy D. et al. Peritoneal involvement in stage II colon cancer. Am. J. Clin. Pathol., 2003, 119: 108-113.
67. MULCAHY H.E., TONER M., PATCHETT S.E., DALY L., O'DONOGHUE D.P. Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death. Dis. Colon. Rectum, 1997, 40: 326-331.
68. KHANKHANIAN N., MAVLIGIT G.M., RUSSELL W.O., SCHIMEK M. Prognostic significance of vascular invasion in colorectal cancer of Dukes' B class. Cancer, 1977, 39: 1195-1200.
69. TYTHERLEIGH M.G., WARREN B.F., MORTENSEN N.J. Management of early rectal cancer. Br. J. Surg., 2008, 95: 409-423.
70. DEINLEIN P., REULBACH U., STOLTE M., VIETH M. Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma. Pathologe, 2003, 24: 387-393.
71. TATEISHI Y., NAKANISHI Y., TANIGUCHI H., SHIMODA T., UMEMURA S. Pathological prognostic factors predicting lymph node metastasis in submucosal invasive (T1) colorectal carcinoma. Mod. Pathol., 2010, 23: 1068-1072.
72. ISHII M., OTA M., SAITO S., KINUGASA Y., AKAMOTO S., ITO I. Lymphatic vessel invasion detected by monoclonal antibody D2-40 as a predictor of lymph node metastasis in T1 colorectal cancer. Int. J. Colorectal Dis., 2009, 24: 1069-1074.
73. TOMINAGA K., NAKANISHI Y., NIMURA S., YOSHIMURA K., SAKAI Y, SHIMODA T. Predictive histopathologic factors for lymph node metastasis in patients with nonpedunculated submucosal invasive colorectal carcinoma. Dis. Colon. Rectum., 2005, 48: 92-100.
74. WANG H.S., LIANG W.Y., LIN T.C., CHEN W.S., JIANG J.K., YANG S.H. et al. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis. Dis. Colon. Rectum., 2005, 48: 1182-1192.
75. PENG J., CHEN W., SHENG W., XU Y., CAI G., HUANG D. et al. Oncological outcome of T1 rectal cancer undergoing standard resection and local excision. Colorectal Dis., 2011, 13: e14-9.
76. YASUDA K., INOMATA M., SHIROMIZU A., SHIRAISHI N., HIGASHI H., KITANO S. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection. Dis. Colon. Rectum., 2007, 50: 1370-1376.
77. NISSAN A., STOJADINOVIC A., SHIA J., HOOS A., GUILLEM J.G., KLIMSTRA D. et al. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J. Clin. Oncol., 2006, 24: 4078-4084.
78. MERCHANT N.B., GUILLEM J.G., PATY P.B., ENKER W.E., MINSKY B.D., QUAN S.H. et al. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J. Gastrointest. Surg., 1999, 3: 642-647.
79. YUN H.R., LEE L.J., PARK J.H., CHO Y.K., CHO Y.B., LEE W.Y. et al. Local recurrence after curative resection in patients with colon and rectal cancers. Int. J. Colorectal Dis., 2008, 23: 1081-1087.
80. BOUVET M., MILAS M., GIACCO G.G., CLEARY K.R., JANJAN N.A., SKIBBER J.M. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann. Surg. Oncol., 1999, 6: 26-32.
81. POESCHL E.M., POLLHEIMER M.J., KORNPRAT P., LINDTNER R.A., SCHLEMMER A., REHAK P. et al. Perineural invasion: correlation with aggressive phenotype and independent prognostic variable in both colon and rectum cancer. J. Clin. Oncol., 2010, 28: e358-360.
82. SATO T., UENO H., MOCHIZUKI H., SHINTO E., HASHIGUCHI Y., KAJIWARA Y. et al. Objective criteria for the grading of venous invasion in colorectal cancer. Am. J. Surg. Pathol., 2010, 34: 454-462.
83. STERNBERG A., MIZRAHI A., AMAR M., GROISMAN G. Detection of venous invasion in surgical specimens of colorectal carcinoma: the efficacy of various types of tissue blocks. J. Clin. Pathol., 2006, 59: 207-210.
84. LITTLEFORD S.E., BAIRD A., ROTIMI O., VERBEKE C.S., SCOTT N. Interobserver variation in the reporting of local peritoneal involvement and extramural venous invasion in colonic cancer. Histopathology, 2009, 55: 407-413.
85. VASS D.G., AINSWORTH R., ANDERSON J.H., MURRAY D., FOULIS A.K. The value of an elastic tissue stain in detecting venous invasion in colorectal cancer. J. Clin. Pathol., 2004, 57: 769-772.
86. STERNBERG A., AMAR M., ALFICI R., GROISMAN G. Conclusions from a study of venous invasion in stage IV colorectal adenocarcinoma. J. Clin. Pathol., 2002, 55: 17-21.
87. KINGSTON E.F., GOULDING H., BATEMAN A.C. Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis. Colon. Rectum., 2007, 50: 1867-1872.
88. ABDULKADER M., ABDULLA K., RAKHA E., KAYE P. Routine elastic staining assists detection of vascular invasion in colorectal cancer. Histopathology, 2006, 49: 487-492.
89. ROXBURGH C.S., MCMILLAN D.C., ANDERSON J.H., MCKEE R.F., HORGAN P.G., FOULIs A.K. Elastica staining for venous invasion results in superior prediction of cancer-specific survival in colorectal cancer. Ann. Surg., 2010, 252: 989-997.
90. COMPTON C.C. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod. Pathol., 2003, 16: 376-388.
91. HARRIS E.I., LEWIN D.N., WANG H.L., LAUWERS G.Y., SRIVASTAVA A., SHYR Y. et al. Lymphovascular invasion in colorectal cancer: an interobserver variability study. Am. J. Surg. Pathol., 2008, 32: 1816-1821.
92. COMPTON C.C., FIELDING L.P., BURGART L.J., CONLEY B., COOPER H.S., HAMILTON S.R. et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch. Pathol. Lab. Med., 2000, 124: 979-994.
93. BATSAKIS J.G. Nerves and neurotropic carcinomas. Ann. Otol. Rhinol. Laryngol., 1985, 94: 426-427.
94. LIEBIG C., AYALA G., WILKS J.A., BERGER D.H., ALBO D. Perineural invasion in cancer: a review of the literature. Cancer, 2009, 115: 3379-3391.
95. PENG J., SHENG W., HUANG D., VENOOK A.P., XU Y., GUAN Z. et al. Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect. Cancer, 2011, 117: 1415-1421.
96. LiEBIG C., AYALA G., WILKS J., VERSTOVSEK G., LIU H., AGARWAL N. et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J. Clin. Oncol., 2009, 27: 5131-5137.
97. RODIN A.E., LARSON D.L., ROBERTS D.K. Nature of the perineural space invaded by prostatic carcinoma. Cancer, 1967, 20: 1772-1779.
98. HASSAN M.O., MAKSEM J. The prostatic perineural space and its relation to tumor spread: an ultrastructural study. Am. J. Surg. Pathol., 1980, 4: 143-148.
99. MATSUSHIMA T., MORI M., KIDO A., ADACHI Y., SUGIMACHI K. Preoperative estimation of neural invasion in rectal carcinoma. Oncol. Rep., 1998, 5: 73-76.
100. SHIROUZU K., ISOMOTO H., KAKEGAWA T. Prognostic evaluation of perineural invasion in rectal cancer. Am. J. Surg., 1993, 165: 233-237.
101. SHIROUZU K., ISOMOTO H., MORODOMI T., ARAKI Y., HOSHIKO M., AKAGI Y. et al. Clinicopathologic study of perineural invasion in rectal cancer. Kurume Med. J., 1992, 39: 41-49.
102. BOGNEL C., REKACEWICZ C., MANKARIOS H., PIGNON J.P., ELIAS D., DUVILLARD P. et al. Prognostic value of neural invasion in rectal carcinoma: a multivariate analysis on 339 patients with curative resection. Eur. J. Cancer, 1995, 31A: 894-898.
103. STEWART D., YAN Y., MUTCH M., KODNER I., HUNT S., LOWNEY J. et al. Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy. Colorectal Dis., 2008, 10: 879-886.
104. TSAI H.L., CHU K.S., HUANG Y.H., SU Y.C., WU J.Y., KUO C.H. et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J. Surg. Oncol., 2009, 100: 736-743.
105. OH S.Y., KIM Y.B., PAEK O.J., SUH K.W. Contiguous invasion per se does not affect prognosis in colon cancer. J. Surg. Oncol., 2009, 99: 71-74.
106. UENO H., HASE K., MOCHIZUKI H. Criteria for extramural perineural invasion as a prognostic factor in rectal cancer. Br. J. Surg., 2001, 88: 994-1000.
107. LAW W.L., CHU K.W. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann. Surg., 2004, 240: 260-268.
108. UEHARA K., NAKANISHI Y., SHIMODA T., TANIGUCHI H., AKASU T., MORIYA Y. Clinicopathological significance of microscopic abscess formation at the invasive margin of advanced low rectal cancer. Br. J. Surg., 2007, 94: 239-243.
109. KANG H., MIN B.S., LEE K.Y., KIM N.K., KIM S.N., CHOI J. et al. Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma. Ann. Surg. Oncol., 2011, 18: 711-719.
110. CHUANG S.C., SU Y.C., LU C.Y., HSU H.T., SUN L.C., SHIH Y.L. et al. Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection. World. J. Surg., 2011, 35: 424-429.
111. DERICI H., UNALP H.R., KAMER E., BOZDAG A.D., TANSUG T., NAZLI O. et al. Multivisceral resections for locally advanced rectal cancer. Colorectal Dis., 2008, 10: 453-459.
112. HUH J.W., KIM H.R., KIM Y.J. Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann. Surg. Oncol., 2010, 17: 2066-2072.
113. LAW W.L., HO J.W., CHAN R., AU G., CHU K.W. Outcome of anterior resection for stage II rectal cancer without radiation: the role of adjuvant chemotherapy. Dis. Colon. Rectum, 2005, 48: 218-226.
114. TSAI H.L., YEH Y.S., YU F.J., LU C.Y., CHEN C.F., CHEN C.W. et al. Predicting factors of postoperative relapse in T2-4N0M0 colorectal cancer patients via harvesting a minimum of 12 lymph nodes. Int. J. Colorectal. Dis., 2009, 24: 177-183.
115. BURDY G., PANIS Y., ALVES A., NEMETH J., LAVERGNE-SLOVE A., VALLEUR P. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis. Colon. Rectum, 2001, 44: 1682-1688.
116. DESOLNEUX G., BURTIN P., LERMITE E., BERGAMASCHI R., HAMY A., ARNAUD J.P. Prognostic factors in node-negative colorectal cancer: a retrospective study from a prospective database. Int. J. Colorectal. Dis., 2010, 25: 829-834.
117. ONATE-OCANA L.F., MONTESDEOCA R., LOPEZ-GRANIEL C.M., AIELLO-CROCIFOGLIO V., MONDRAGON-SANCHEZ R., CORTINABORJA M. et al. Identification of patients with high-risk lymph nodenegative colorectal cancer and potential benefit from adjuvant chemo-therapy. Jpn. J. Clin. Oncol., 2004, 34: 323-328.
118. DI FABIO F., NASCIMBENI R., VILLANACCI V., BARONCHELLI C., BIANCHI D., FABBRETTI G. et al. Prognostic variables for cancer-related survival in node-negative colorectal carcinomas. Dig. Surg., 2004, 21: 128-133.
119. HUH J.W., KIM H.R., KIM Y.J. Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J. Gastrointest. Surg., 2010, 14: 1074-1080.
120. CHOI D.H., SOHN D.K., CHANG H.J., LIM S.B., CHOI H.S., JEONG S.Y. Indications for subsequent surgery after endoscopic resection of submucosally invasive colorectal carcinomas: a prospective cohort study. Di. s Colon. Rectum., 2009, 52: 438-445.
121. ENKER W.E., HAVENGA K., POLYAK T., THALER H., CRANOR M. Abdomino perineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer. World J. Surg., 1997, 21: 715-720.
122. BENTZEN S.M., BALSLEV I., PEDERSEN M., TEGLBJAERG P.S., HANBERG-SORENSEN F., BONE J. et al. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br. J. Cancer, 1992, 65: 102-107.
123. AKASU T., TAKAWA M., YAMAMOTO S., ISHIGURO S., YAMAGUCHI T., FUJITA S. et al. Intersphincteric resection for very low rectal adenocarcinoma: univariate and multivariate analyses of risk factors for recurrence. Ann. Surg. Oncol., 2008, 15: 2668-2676.
124. PENG. J, SHENG W., HUANG D., VENOOK A.P., XU Y., GUAN Z. et al. Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect. Cancer, 2010, 117: 1415-1421.
125. BELLIS D., MARCI V., MONGA G. Light microscopic and immunohistochemical evaluation of vascular and neural invasion in colorectal cancer. Pathol. Res. Pract., 1993, 189: 443-447.
126. KURTZ K.A., HOFFMAN H.T., ZIMMERMAN M.B., ROBINSON R.A. Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch. Pathol. Lab. Med., 2005, 129: 354-359.
127. ZHOU M., PATEL A., RUBIN M.A. Prevalence and location of peripheral nerve found on prostate needle biopsy. Am. J. Clin. Pathol., 2001, 115: 39-43.
128. JASS J.R., ATKIN W.S., CUZICK J., BUSSEY H., MORSON B.C., NORTHOVER J.M. et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology, 1986, 10: 437-459.
129. UENO H., MURPHY J., JASS J.R., MOCHIZUKI H., TALBOT I.C. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology, 2002, 40: 127-132.
130. HASE K., SHATNEY C., JOHNSON D., TROLLOPE M., VIERRA M. Prognostic value of tumor "budding" in patients with colorectal cancer. Dis. Colon. Rectum, 1993, 36: 627-635.
131. GABBERT H., WAGNER R., MOLL R., GERHARZ C.D. Tumor dedifferentiation: an important step in tumor invasion. Clin. Exp. Metastasis. 1985, 3: 257-279.
132. ZLOBEC I., LUGLI A. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J. Gastroenterol., 2009, 15: 5898-5906.
133. PRALL F. Tumour budding in colorectal carcinoma. Histopathology. 2007, 50: 151-162.
134. KANAZAWA H., MITOMI H., NISHIYAMA Y., KISHIMOTO I., FUKUI N., NAKAMURA T. et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis., 2008, 10: 41-47.
135. ZLOBEC I., TERRACCIANO L., TORNILLO L., GUNTHERT U., VUONG T., JASS J.R. et al. Role of RHAMM within the hierarchy of wellestablished prognostic factors in colorectal cancer. Gut., 2008, 57: 1413-1419.
136. UENO H., PRICE A.B., WILKINSON K.H., JASS J.R., MOCHIZUKI H., TALBOT I.C. A new prognostic staging system for rectal cancer. Ann. Surg., 2004, 240: 832-839.
137. OKUYAMA T., NAKAMURA T., YAMAGUCHI M. Budding is useful to select high-risk patients in stage II well-differentiated or moderately differentiated colon adenocarcinoma. Dis. Colon. Rectum, 2003, 46: 1400-1406.
138. OHTSUKI K., KOYAMA F., TAMURA T., ENOMOTO Y., FUJII H., MUKOGAWA T. et al. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res., 2008, 28: 1831-1836.
139. PARK K.J., CHOI H.J., ROH M.S., KWON H.C., KIM C. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis. Colon. Rectum, 2005, 48: 1597-1602.
140. CHOI H.J., PARK K.J., SHIN J.S., ROH M.S., KWON H.C., LEE H.S. Tumor budding as a prognostic marker in stage-III rectal carcinoma. Int. J. Colorectal Dis., 2007, 22: 863-868.
141. SY J., FUNG C.L., DENT O.F., CHAPUIS P.H., BOKEY L., CHAN C. Tumor budding and survival after potentially curative resection of nodepositive colon cancer. Dis. Colon. Rectum, 2010, 53: 301-307.
142. NAKAMURA T., MITOMI H., KIKUCHI S., OHTANI Y., SATO K. Evaluation of the usefulness of tumor budding on the prediction of metastasis to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterology, 2005, 52: 1432-1435.
143. UENO H., MOCHIZUKI H., HASHIGUCHI Y., HATSUSE K., FUJIMOTO H., HASE K. Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br. J. Surg., 2004, 91: 327-333.
144. MARKL B., RENK I., ORUZIO D.V., JAHNIG H., SCHENKIRSCH G., SCHOLER C. et al. Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer. J. Surg. Oncol., 2010, 102: 235-241.
145. ZLOBEC I., BAKER K., MINOO P., JASS J.R., TERRACCIANO L., LUGLI A. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin. Cancer Res., 2008, 14: 143-148.
146. IWAYA K., OIKAWA K., SEMBA S., TSUCHIYA B., MUKAI Y., OTSUBO T. et al. Correlation between liver metastasis of the colocalization of actin-related protein 2 and 3 complex and WAVE2 in colorectal carcinoma. Cancer Sci., 2007, 98: 992-999.
147. NAKAMURA T., MITOMI H., KANAZAWA H., OHKURA Y., WATANABE M. Tumor budding as an index to identify high-risk patients with stage II colon cancer. Dis. Colon. Rectum, 2008, 51: 568-572.
148. TANAKA M., HASHIGUCHI Y., UENO H., HASE K., MOCHIZUKI H. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer. Dis. Colon. Rectum, 2003, 46: 1054-1059.
149. WANG L.M., KEVANS D., MULCAHY H., O'SULLIvan J., FENNELLY D., HYLAND J. et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am. J. Surg. Pathol., 2009, 33: 134-141.
150. PRALL F., NIZZE H., BARTEN M. Tumour budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology, 2005, 47: 17-24.
151. SHINTO E., JASS J.R., TSUDA H., SATO T., UENO H., HASE K. et al. Differential prognostic significance of morphologic invasive markers in colorectal cancer: tumor budding and cytoplasmic podia. Dis. Colon. Rectum., 2006, 49: 1422-1430.
152. YOSHIDA K., YOSHIMATSU K., OTANI T., YOKOMIZO H., OGAWA K. The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer. Anticancer Res., 2008, 28: 1773-1778.
153. OKUYAMA T., OYA M., ISHIKAWA H. Budding as a useful prognostic marker in pT3 well-or moderately-differentiated rectal adenocarcinoma. J. Surg. Oncol., 2003, 83: 42-47.
154. OGAWA T., YOSHIDA T., TSURUTA T., TOKUYAMA W., ADACHI S., KIKUCHI M. et al. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcino-mas and in non-polypoid compared with polypoid growths. Scand. J. Gastroenterol., 2009, 44: 605-614.
155. ISHIKAWA Y., AKISHIMA-FUKASAWA Y., ITO K., AKASAKA Y., YOKOO T., ISHII T. et al. Histopathologic determinants of regional lymph node metastasis in early colorectal cancer. Cancer, 2008, 112: 924-933.
156. YAMAUCHI H., TOGASHI K., KAWAMURA Y.J., HORIE H., SASAKI J., TSUJINAKA S. et al. Pathological predictors for lymph node metastasis in T1 colorectal cancer. Surg. Today, 2008, 38: 905-910.
157. KANEKO I., TANAKA S., OKA S., YOSHIDA S., HIYAMA T., ARIHIRO K. et al. Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J. Gastroenterol., 2007, 13: 3829-3835.
158. MASAKI T., MATSUOKA H., SUGIYAMA M., ABE N., SAKAMOTO A., ATOMI Y. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J. Gastroenterol. Hepatol., 2006, 21: 1115-1121.
159. HASE K., SHATNEY Ch., MOCHIZUKI H., JOHNSON D.L., TAMAKUMA S., VIERRA M. et al. Long-term results of curative resection of "minimally invasive" colorectal cancer. Dis. Colon. Rectum, 1995, 38: 19-26.
160. UENO H., MOCHIZUKI H., HASHIGUCHI Y., SHIMAZAKI H., AIDA S., HASE K. et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology, 2004, 127: 385-394.
161. KOMORI K., HIRAI T., KANEMITSU Y., SHIMIZU Y., SANO T., ITO S. et al. Is "depth of submucosal invasion > or = 1,000 microm" an important predictive factor for lymph node metastases in early invasive colorectal cancer (pT1)? Hepatogastroenterology, 2010, 57: 1123-1127.
162. KAZAMA S., WATANABE T., AJIOKA Y., KANAZAWA T., NAGAWA H. Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br. J. Cancer, 2006, 94: 293-298.
163. MASAKI T., SUGIYAMA M., MATSUOKA H., ABE N., IZUMISATO Y., GOTO A. et al. Clinical utility of grading criteria for submucosal invasion in the prognosis of T1 colorectal carcinomas. J. Gastroenterol., 2003, 38: 37-44.
164. MASAKI T., GOTO A., SUGIYAMA M., MATSUOKA H., ABE N., SAKAMOTO A. et al. Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma. Cancer, 2001, 92: 2539-2546.
165. SYK E., LENANDER C., NILSSON P.J., RUBIO C.A., GLIMELIUS B. Tumour budding correlates with local recurrence of rectal cancer. Colorectal Dis., 2011, 13: 255-262.
166. ZLOBEC I., MOLINARI F., MARTIN V., MAZZUCCHELLI L., SALETTI P., TREZZI R. et al. Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients. World J. Gastroenterol., 2010, 16: 4823-4831.
167. KAJIWARA Y., UENO H., HASHIGUCHI Y., MOCHIZUKI H., HASE K. Risk factors of nodal involvement in T2 colorectal cancer. Dis. Colon. Rectum, 2010, 53: 1393-1399.
168. MORODOMI T., ISOMOTO H., SHIROUZU K., KAKEGAWA K., IRIE K., MORIMATSU M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer, 1989, 63: 539-543.
169. OKUYAMA T., OYA M., ISHIKAWA H. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis. Colon. Rectum., 2002, 45: 628-634.